Matches in Wikidata for { <http://www.wikidata.org/entity/Q94470175> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q94470175 description "article scientifique publié en 2020" @default.
- Q94470175 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q94470175 description "scientific article published on 15 April 2020" @default.
- Q94470175 description "wetenschappelijk artikel" @default.
- Q94470175 description "наукова стаття, опублікована 15 квітня 2020" @default.
- Q94470175 name "Eligibility and implementation of disease-modifying therapy for primary progressive multiple sclerosis in a UK cohort" @default.
- Q94470175 name "Eligibility and implementation of disease-modifying therapy for primary progressive multiple sclerosis in a UK cohort" @default.
- Q94470175 type Item @default.
- Q94470175 label "Eligibility and implementation of disease-modifying therapy for primary progressive multiple sclerosis in a UK cohort" @default.
- Q94470175 label "Eligibility and implementation of disease-modifying therapy for primary progressive multiple sclerosis in a UK cohort" @default.
- Q94470175 prefLabel "Eligibility and implementation of disease-modifying therapy for primary progressive multiple sclerosis in a UK cohort" @default.
- Q94470175 prefLabel "Eligibility and implementation of disease-modifying therapy for primary progressive multiple sclerosis in a UK cohort" @default.
- Q94470175 P1433 Q94470175-FF8427F8-0BFA-4D31-8668-822977554481 @default.
- Q94470175 P1476 Q94470175-42DB7ACA-F9F3-48C9-8DE2-6380F109093B @default.
- Q94470175 P2093 Q94470175-3B5D9FBD-3826-4BB8-ADA9-9DF8B2FCD7D9 @default.
- Q94470175 P2093 Q94470175-6C5300CD-4739-4634-95D8-A0F055B863D4 @default.
- Q94470175 P2093 Q94470175-83E49E6B-8315-46F0-BD26-B8F1AF82FFF7 @default.
- Q94470175 P2093 Q94470175-ADFBB555-62C7-402A-B82C-50494F10FF64 @default.
- Q94470175 P2093 Q94470175-B4CF6F67-5E51-42A6-B288-C9018722B6CF @default.
- Q94470175 P2093 Q94470175-EE77BC04-D2AF-47B1-91EE-D1B673AB0319 @default.
- Q94470175 P304 Q94470175-BC81869F-C2B6-467E-809E-553572678CF3 @default.
- Q94470175 P31 Q94470175-D1EEF1E3-19A5-4B49-A21A-F2DC631325CB @default.
- Q94470175 P356 Q94470175-3867641D-BB45-4622-90B3-09C69EF97B56 @default.
- Q94470175 P478 Q94470175-E34713ED-82BE-4C72-A448-78A2FAC56BB4 @default.
- Q94470175 P50 Q94470175-DF5BBD49-0D5A-4619-A9DD-56A788A95172 @default.
- Q94470175 P577 Q94470175-0CB6D6CC-853D-4B44-885A-B8DDC118D255 @default.
- Q94470175 P698 Q94470175-4F4EBA0E-110B-4530-9BDC-ED6E48CE5D04 @default.
- Q94470175 P921 Q94470175-0B13FAAE-26DE-457D-AECE-1236E925B4EC @default.
- Q94470175 P356 J.MSARD.2020.102056 @default.
- Q94470175 P698 32353753 @default.
- Q94470175 P1433 Q26842267 @default.
- Q94470175 P1476 "Eligibility and implementation of disease-modifying therapy for primary progressive multiple sclerosis in a UK cohort" @default.
- Q94470175 P2093 "Daniel Castle" @default.
- Q94470175 P2093 "Fady Joseph" @default.
- Q94470175 P2093 "Katharine E Harding" @default.
- Q94470175 P2093 "Neil P Robertson" @default.
- Q94470175 P2093 "Paul Karamura" @default.
- Q94470175 P2093 "Thomas A W Brice" @default.
- Q94470175 P304 "102056" @default.
- Q94470175 P31 Q13442814 @default.
- Q94470175 P356 "10.1016/J.MSARD.2020.102056" @default.
- Q94470175 P478 "42" @default.
- Q94470175 P50 Q58517218 @default.
- Q94470175 P577 "2020-04-15T00:00:00Z" @default.
- Q94470175 P698 "32353753" @default.
- Q94470175 P921 Q18553470 @default.